Sartorius Stedim Biotech S.A. Unsponsored ADR logo

Sartorius Stedim Biotech S.A. Unsponsored ADR (56S0)

Market Closed
17 Jul, 20:00
XFRA XFRA
18. 10
-0.4
-2.1622%
19.19B Market Cap
- P/E Ratio
0.3% Div Yield
13 Volume
- Eps
18.5
Previous Close
Add Transaction
Day Range
18.1 18.1
Year Range
14.6 21.8
Want to track 56S0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

56S0 closed today lower at €18.1, a decrease of -2.1622% from yesterday's close, completing a monthly increase of 4.023% or €0.7. Over the past 12 months, 56S0 stock lost -11.2745%.
56S0 pays dividends to its shareholders, with the most recent payment made on Apr 17, 2026. The next estimated payment will be in In 8 months on Apr 17, 2027 for a total of €0.04375.
The last earnings report, released on Jan 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

56S0 Chart

People also search for

SAP SE Depositary Receipt
3.12
+4%
Nvidia Corporation Unsponsored Depositary Receipt
7
+5.2632%
ABE
ABE
8.5
-6.0773%
Apple Inc. Depositary Receipt (APC0)
7.25
+1.3986%
Intel Corporation Depositary Receipt
14.8
-9.7561%

Sartorius Stedim Biotech S.A. Unsponsored ADR (56S0) FAQ

What is the stock price today?

The current price is €18.10.

On which exchange is it traded?

Sartorius Stedim Biotech S.A. Unsponsored ADR is listed on XFRA.

What is its stock symbol?

The ticker symbol is 56S0.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.3%.

What is its market cap?

As of today, the market cap is 19.19B.

Has Sartorius Stedim Biotech S.A. Unsponsored ADR ever had a stock split?

No, there has never been a stock split.

Sartorius Stedim Biotech S.A. Unsponsored ADR Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Rene Faber CEO
XFRA Exchange
80386Y101 CUSIP
FR Country
10,456 Employees
1 Apr 2026 Last Dividend
- Last Split
- IPO Date

Overview

Sartorius Stedim Biotech S.A., a prominent entity in the biopharmaceutical industry, is dedicated to manufacturing and distributing a vast range of instruments and consumables worldwide. Since its establishment in 1978 and headquartered in Aubagne, France, the company has been at the forefront of supporting the biopharmaceutical sector. Its clientele includes major manufacturers of medications, vaccines, foods, chemicals, and research and development laboratories. As of December 31, 2023, it functions under the umbrella of Sartorius AG, marking a significant affiliation that enhances its capabilities and service reach.

Products and Services

  • Cell Lines & Culture Media: Essential tools for biopharmaceutical research, including genetically modified cell lines and nutrient-rich media for cell growth.
  • Bioreactors & Advanced Therapies: State-of-the-art equipment for the cultivation of cells under controlled environments, pivotal for developing advanced therapeutic products.
  • Separation, Purification, and Concentration Products: A comprehensive suite of products designed for the critical stages of biopharmaceutical processing, ensuring the purity and potency of biotherapeutics.
  • Storage and Transportation Systems: Solutions for the safe handling, storage, and transport of intermediate and finished biological products, maintaining their integrity throughout the supply chain.
  • Bioprocessing Services: Offers assistance in cell cultivation, fermentation, separation, purification, and fluid management, streamlining the biomanufacturing process.
  • Biolayer Interferometry Instruments & Microbiology Tools: Advanced instruments for the analysis of biomolecular interactions and microbiology enumeration, crucial for ensuring product safety and efficacy.
  • Lab Instruments and Data Management: Includes pipettes, sensors, analyzers, and software solutions for lab data and fleet management, enhancing research productivity and data integrity.
  • Biomolecule Analysis Tools & Flow Cytometry: Cutting-edge technologies for the in-depth study of biomolecules and cell characteristics, supporting the development of novel biopharmaceuticals.
  • Chromatography Systems: Advanced systems for batch and intensified chromatography, vital in the purification steps of drug development.
  • Live Cell Imaging & Analysis: Innovative solutions for real-time observation of cellular processes, aiding in the study of cell biology and drug responses.
  • Data Analytics & Process Automation Software: Sophisticated software for modeling, optimizing biopharmaceutical development, and production processes, alongside automation platforms for increased efficiency.
  • Transfection Reagents & Plasmid DNA Production: Essential components and services for gene delivery, facilitating research in gene therapy and recombinant protein production.

Contact Information

Address: Zone Industrielle Les Paluds
Phone: 33 4 42 84 56 00